Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Frontiers in Psychiatry|December 19, 2019
The Bridge Between Classical and "Synthetic"/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic PerspectiveLaura Orsolini, Stefania Chiappini, Duccio Papanti, et al.
Frontiers in Psychiatry|July 15, 2026
Case Report: Trazodone as a possible treatment for psychiatric adverse events related to ALK inhibitorsLuca Persico, Andrea Miuli, Stefania Chiappini, et al.
Expert Review of Neurotherapeutics|February 27, 2025
Emerging strategies and clinical recommendations for the management of novel depression subtypesStefania Chiappini, Gaia Sampogna, Antonio Ventriglio, et al.
Human Psychopharmacology|July 29, 2015
Deaths of individuals aged 16-24 years in the UK after using mephedroneBarbara Loi, John Martin Corkery, Hugh Claridge, et al.
The New Microbiologica|May 28, 2011
Quantitative viral load measurement for BKV infection in renal transplant recipients as a predictive tool for BKVANCaterina Patrizia Pollara, Silvia Corbellini, Stefania Chiappini, et al.
Frontiers in Psychiatry|July 17, 2025
Exploring emerging psychopathological characteristics and challenges of novel depression subtypes: insights from the literatureStefania Chiappini, Gaia Sampogna, Antonio Ventriglio, et al.
Pharmaceuticals (Basel, Switzerland)|April 27, 2024
3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an 18F-FDG PET/CT Case ReportMaria Pepe, Marco Di Nicola, Fabrizio Cocciolillo, et al.
Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology|April 23, 2021
'Z-trip'? A Comprehensive Overview and a Case-series of Zolpidem MisuseLaura Orsolini, Stefania Chiappini, Paolo Grandinetti, et al.
Pharmaceuticals (Basel, Switzerland)|June 24, 2022
Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS)Stefania Chiappini, Rachel Vickers-Smith, Amira Guirguis, et al.
Brain Sciences|November 27, 2025
Possible Eye Disorders in Children Prenatally Exposed to Either Methadone or Buprenorphine in Comparison with Other Medications: An Examination of the Food and Drug Administration (FDA) Pharmacovigilance DatabaseStefania Chiappini, Laura Orsolini, John Martin Corkery, et al.
Pageof 9